Epigenetics - Relevance to drug safety science

Toxicology Research

Volumn 1, Issue 1, 2012, Pages 23-31

  Priestley, Catherine C ^a   Anderton, Mark ^a   Doherty, Ann T ^a   Duffy, Paul ^a   Mellor, Howard R ^a   Powell, Helen ^a   Roberts, Ruth ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; UNTRANSLATED RNA; XENOBIOTIC AGENT;

DNA METHYLATION; DRUG RESPONSE; DRUG SAFETY; ENVIRONMENTAL FACTOR; EPIGENETICS; GENOTOXICITY; HISTONE MODIFICATION; HUMAN; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE;

EID: 84877931024     PISSN: 2045452X     EISSN: 20454538     Source Type: Journal    
DOI: 10.1039/c2tx00003b     Document Type: Review

References (75)

1. B. E. Bernstein A. Meissner E. S. Lander The mammalian epigenome Cell 2007 128 669 681 (Pubitemid 46273573)
2. A. P. Feinberg The epigenetics of cancer etiology Semin. Cancer Biol. 2004 14 6 427 432 (Pubitemid 39360990)
3. M. Esteller M. E. Fraga M. Guo J. Garcia-Fonciilas I. Hedenfalk A. K. Godwin J. Trojan C. Vaurs-Barriere Y. J. Bignon S. Ramus J. Benitez T. Caldes Y. Akiyama Y. Yuasa V. Launonen M. J. Canal R. Rodriguez G. Capella M. A. Peinado A. Borg L. A. Aaltonen B. A. Ponder S. B. Baylin J. G. Herman DNA methylation patterns in hereditary human cancer mimics sporadic tumorigenesis Hum. Mol. Genet. 2001 10 3001 3007 (Pubitemid 34083486)
4. I. P. Pogribny I. Rusyn F. A. Beland Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents Environ. Mol. Mutagen. 2008 49 1 9 15 (Pubitemid 351293008)
5. HESI, 2010, http://www.hesiglobal.org/files/public/ 2010%20Annual%20Meeting/Presentations/EI/05-Augustine-Epigenetics.pdf
6. S. M. Reamon-Buettner J. Borlak A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation Reprod. Toxicol. 2007 24 1 20 30 (Pubitemid 47042357)
7. M. Szyf The dynamic epigenome and its implications in toxicology Toxicol. Sci. 2007 100 1 7 23 (Pubitemid 47617798)
8. J. H. Martens H. G. Stunnenberg C. Logie The decade of the epigenomes? Genes Cancer 2011 2 6 680 687
9. A. M. Osman D. A. van Dartel E. Zwart M. Blokland J. L. Pennings A. H. Piersma Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity Reprod. Toxicol. 2010 30 2 322 332
10. J. E. Trosko C. C. Chang Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment Toxicology 2010 270 1 18 34
11. A. Dhasarathy P. A. Wade The MBD protein family-reading an epigenetic mark? Mutat. Res., Fundam. Mol. Mech. Mutagen. 2008 647 1-2 39 43
12. M. J. LeBaron R. J. Rasoulpour J. Klapacz R. G. Ellis-Hutchings H. M. Hollnagel B. B. Gollapudi Epigenetics and chemical safety assessment Mutat. Res., Rev. Mutat. Res. 2010 705 2 83 95
13. F. Eckhardt J. Lewin R. Cortese V. K. Rakyan J. Attwood M. Burger J. Burton T. V. Cox R. Davies T. A. Down C. Haefliger R. Horton K. Howe D. K. Jackson J. Kunde C. Koenig J. Liddle D. Niblett T. Otto R. Pettett S. Seemann C. Thompson T. West J. Rogers A. Olek K. Berlin K. Beck DNA methylation profiling of human chromosomes 6, 20 and 22 Nat. Genet. 2006 38 12 1378 1385 (Pubitemid 44837559)
14. P. W. Laird The power and the promise of DNA methylation markers Nat. Rev. Cancer 2003 3 4 253 266 (Pubitemid 37328861)
15. C. Dahl P. Guldberg DNA methylation analysis techniques Biogerontology 2003 4 4 233 250 (Pubitemid 37098463)
16. S. M. Ho W. Y. Tang Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases Reprod. Toxicol. 2007 23 3 267 282
17. I. Keshet Y. Schlesinger S. Farkash E. Rand M. Hecht E. Segal E. Pikarski R. A. Young A. Niveleau H. Cedar I. Simon Evidence for an instructive mechanism of de novo methylation in cancer cells Nat. Genet. 2006 38 2 149 153 (Pubitemid 43177227)
18. I. M. Wilson J. J. Davies M. Weber C. J. Brown C. E. Alvarez C. MacAulay D. Schubeler W. L. Lam Epigenomics: mapping the methylome Cell Cycle 2006 5 155 158 (Pubitemid 43131150)
19. D. M. Duhl H. Vrieling K. A. Miller G. L. Wolff G. S. Barsh Neomorphic agouti mutations in obese yellow mice Nat. Genet. 1994 8 59 65 (Pubitemid 24274061)
20. T. J. Vasicek L. Zeng X. J. Guan T. Zhang F. Costantini S. M. Tilghman Two dominant mutations in the mouse fused gene are the result of transposon insertions Genetics 1997 147 777 786 (Pubitemid 27418585)
21. R. Druker T. J. Bruxner N. J. Lehrbach E. Whitelaw Complex patterns of transcription at the insertion site of a retrotransposon in the mouse Nucleic Acids Res. 2004 32 5800 5808 (Pubitemid 39619162)
22. R. A. Waterland R. L. Jirtle Transposable elements: targets for early nutritional effects on epigenetic gene regulation Mol. Cell. Biol. 2003 23 5293 5300 (Pubitemid 36950884)
23. D. C. Dolinoy J. R. Weidman R. A. Waterland R. L. Jirtle Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome Environ. Health Perspect. 2006 114 567 572
24. G. L. Wolff R. L. Kodell S. R. Moore C. A. Cooney Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice FASEB J. 1998 12 949 957 (Pubitemid 28359576)
25. R. A. Waterland R. L. Jirtle Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases Nutrition 2004 20 63 68 (Pubitemid 38091581)
26. C. A. Cooney A. A. Dave G. L. Wolff Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring J. Nutr. 2002 132 2393S 2400S (Pubitemid 34848114)
27. J. I. Goodman K. A. Augustine M. L. Cunningham D. Dixon Y. P. Dragan J. G. Falls R. J. Rasoulpour R. C. Sills R. D. Storer D. C. Wolf S. D. Pettit What do we need to know prior to thinking about incorporating an epigenetic evaluation into safety assessments? Toxicol. Sci. 2010 116 2 375 381
28. A. Vaquero A. Loyola D. Reinberg The constantly changing face of chromatin Sci. Aging Knowledge Environ. 2003 14 RE4
29. H. Hou H. Yu Structural insights into histone lysine demethylation Curr. Opin. Struct. Biol. 2010 20 6 739 748
30. G. L. Cuthbert S. Daujat A. W. Snowden H. Erdjument-Bromage T. Hagiwara M. Yamada R. Schneider P. D. Gregory P. Tempst A. J. Bannister T. Kouzarides Histone deimination antagonizes arginine methylation Cell 2004 118 5 545 553 (Pubitemid 39179708)
31. J. K. Kim M. Samaranayake S. Pradhan Epigenetic mechanisms in mammals Cell. Mol. Life Sci. 2009 66 4 596 612
32. B. Wold R. M. Myers Sequence census methods for functional genomics Nat. Methods 2008 5 19 21
33. G. Robertson M. Hirst M. Bainbridge M. Bilenky Y. Zhao T. Zeng G. Euskirchen B. Bernier R. Varhol A. Delaney N. Thiessen O. L. Griffith A. He M. Marra M. Snyder S. Jones Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing Nat. Methods 2007 4 8 651 657 (Pubitemid 47202477)
34. J. D. Best N. Carey Epigenetic opportunities and challenges in cancer Drug Discovery Today 2010 15 65 70
35. D. P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 2004 116 281 297
36. B. P. Lewis C. B. Burge D. P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 2005 120 1 15 20 (Pubitemid 40094598)
37. G. A. Calin C. M. Croce MicroRNAs and chromosomal abnormalities in cancer cells Oncogene 2006 25 6202 6210 (Pubitemid 44527851)
38. G. A. Calin C. M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 2006 6 857 866 (Pubitemid 44629897)
39. A. Esquela-Kerscher F. J. Slack Oncomirs - microRNAs with a role in cancer Nat. Rev. Cancer 2006 6 259 269
40. A. Git H. Dvinge M. Salmon-Divon M. Osborne C. Kutter J. Hadfield P. Bertone C. Caldas Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression RNA 2010 16 5 991 1006
41. A. N. Carnell J. I. Goodman The long (LINEs) and the short (SINEs) of it: altered methylation as a precursor to toxicity Toxicol. Sci. 2003 75 2 229 235 (Pubitemid 37220270)
42. S. Baylin T. H. Bestor Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 2002 1 4 299 305 (Pubitemid 41039130)
43. D. C. Dolinoy J. R. Weidman R. L. Jirtle Epigenetic gene regulation: linking early developmental environment to adult disease Reprod. Toxicol. 2007 23 3 297 307 (Pubitemid 46602921)
44. V. Bombail J. G. Moggs G. Orphanides Perturbation of epigenetic status by toxicants Toxicol. Lett. 2004 149 1-3 51 58 (Pubitemid 38469820)
45. F. Grand S. Kulkarni A. Chase J. M. Goldman M. Gordon N. C. Cross Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia Cancer Res. 1999 59 16 3870 3874 (Pubitemid 29393542)
46. M. Takiguchi W. E. Achanzar W. Qu G. Li M. P. Waalkes Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation Exp. Cell Res. 2003 286 355 365 (Pubitemid 36566447)
47. L. Broday W. Peng M. H. Kuo K. Salnikow M. Zoroddu M. Costa Nickel compounds are novel inhibitors of histone H4 acetylation Cancer Res. 2000 60 238 241 (Pubitemid 30070741)
48. S. Marsoni G. Damia G. Camboni A work in progress: the clinical development of histone deacetylase inhibitors Epigenetics 2008 3 3 164 171
49. H. Matsuoka A. Unami T. Fujimura T. Noto Y. Takata K. Yoshizawa H. Mori I. Aramori S. Mutoh Mechanisms of HDAC inhibitor-induced thrombocytopenia Eur. J. Pharmacol. 2007 571 2-3 88 96 (Pubitemid 47379689)
50. E. Menegola F. Di Renzo M. L. Broccia M. Prudenziati S. Minucci V. Massa E. Giavini Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity Birth Defects Res., Part B 2005 74 5 392 398 (Pubitemid 41579582)
51. E. Cornacchia J. Golbus J. Maybaum J. Strahler S. Hanash B. Richardson Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity J. Immunol. 1988 140 2197 2200 (Pubitemid 18098475)
52. C. Arce B. Segura-Pacheco E. Perez-Cardenas L. Taja-Chayeb M. Candelaria A. Dueñnas-Gonzalez Hydralazine target: From blood vessels to the epigenome J. Transl. Med. 2006 4 10
53. P. H. T. Huang W. G. McBride Interaction of [glutarimide-2-14C] thalidomide with rat embryonic DNA in vivo Teratog., Carcinog. Mutagen. 1997 17 1 5 (Pubitemid 27323182)
54. V. P. Tryndyak O. Kovalchuk L. Muskhelishvili B. Montgomery R. Rodriguez-Juarez S. Melnyk S. A. Ross F. A. Beland I. P. Pogribny Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis Mol. Carcinog. 2007 46 3 187 197 (Pubitemid 46399517)
55. N. M. Tsankova O. Berton W. Renthal A. Kumar R. L. Neve E. J. Nestler Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action Nat. Neurosci. 2006 9 519 525
56. A. B. Csoka M. Szyf Epigenetic side-effects of common pharmaceuticals: A potential new field in medicine and pharmacology Med. Hypotheses 2009 73 5 770 780
57. K. S. Sandhu Systems properties of proteins encoded by imprinted genes Epigenetics 2010 5 7 627 636
58. D. Crews J. A. McLachlan Epigenetics, evolution, endocrine disruption, health, and disease Endocrinology 2006 147 6 S4 S10
59. M. D. Anway C. Leathers M. K. Skinner Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease Endocrinology 2006 147 5515 5523 (Pubitemid 44833467)
60. R. R. Newbold R. B. Hanson W. N. Jefferson B. C. Bullock J. Haseman J. A. McLachlan Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol Carcinogenesis 1998 19 1655 1663 (Pubitemid 28441870)
61. R. R. Newbold R. B. Hanson W. N. Jefferson B. C. Bullock J. Haseman J. A. McLachlan Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol Carcinogenesis 2000 21 1355 1363 (Pubitemid 30455995)
62. H. S. Chang M. D. Anway S. S. Rekow M. K. Skinner Transgenerational epigenetic imprinting of the male germline by endocrine disruptor exposure during gonadal sex determination Endocrinology 2006 147 12 5524 5541
63. J. K. Killian C. M. Nolan A. A. Wylie T. Li T. H. Vu A. R. Hoffman R. L. Jirtle Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary Hum. Mol. Genet. 2001 10 1721 1728 (Pubitemid 32899089)
64. M. Ingelman-Sundberg S. C. Sim A. Gomez C. Rodriguez-Antona Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects Pharmacol. Ther. 2007 116 3 496 526 (Pubitemid 350116943)
65. G. J. Hammons Y. Yan-Sanders B. Jin E. Blann F. F. Kadlubar B. D. Lyn-Cook Specific site methylation in the 5′-flanking region of CYP1A2 interindividual differences in human livers Life Sci. 2001 69 7 839 845 (Pubitemid 32619196)
66. R. Ghotbi A. Gomez L. Milani G. Tybring A. C. Syvänen L. Bertilsson M. Ingelman-Sundberg E. Aklillu Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers Pharmacogenomics J. 2009 9 3 208 217
67. W. Habano T. Gamo J. Terashima T. Sugai K. Otsuka G. Wakabayashi S. Ozawa Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells BMC Cancer 2011 11 81
68. C. Rodriguez-Antona A. Gomez M. Karlgren S. C. Sim M. Ingelman-Sundberg Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment Hum. Genet. 2010 127 1 1 17
69. M. Schnekenburger L. Peng A. Puga HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation Biochim. Biophys. Acta, Gene Struct. Expression 2007 1769 9-10 569 578 (Pubitemid 47404659)
70. J. G. Moggs J. I. Goodman J. E. Trosko R. A. Roberts Epigenetics and cancer: implications for drug discovery and safety assessment Toxicol. Appl. Pharmacol. 2004 196 3 422 430 (Pubitemid 38496465)
71. R. E. Watson J. I. Goodman Epigenetics and DNA methylation come of age in toxicology Toxicol. Sci. 2002 67 11 16 (Pubitemid 34520804)
72. E. Buckley Epigenetic effects of chemicals not ready for regulatory "primetime" Pestic. Toxic Chem. News 2009 37
73. B. Hileman, Chemicals can turn genes on and off; new tests needed, scientists say, Environ. Health News, 2009, (2009) August 3
74. R. J. Scheuplein The use of biological data in addition to the carcinogen bioassay in quantitative risk assessment Prog. Clin. Biol. Res. 1995 391 347 357
75. H. Lempiäinen A. Müller S. Brasa S. S. Teo T. C. Roloff L. Morawiec N. Zamurovic A. Vicart E. Funhoff P. Couttet D. Schübeler O. Grenet J. Marlowe J. Moggs R. Terranova Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice PLoS One 2011 6 3 e18216